North America Biocatalyst Market Outlook

the biocatalyst market in north america is expected to experience significant growth in the near future, owing to the increasing demand for renewable energy and environmental tests. the region has seen strong growth in biotechnology industries and the rising demand for enzymes, proteins, and antibodies in the pharmaceutical industry is expected to drive biocatalyst market growth. the increasing demand for cost-effective, molecular markers offering high accuracy and specificity is also boosting the growth of biocatalyst market in the region. in recent years, biocatalyst companies have been investing significantly in the development of innovative biocatalysts. the key players in the region – merck kgaa of germany and novozymes a/s of denmark – have developed novel, efficient, and cost-effective products in the north america biocatalyst market. merck’s biocatalyst portfolio focuses on enzyme engineering and development, while novozymes offers its customers technologies and services in enzyme engineering, fermentation, and analytics. other prominent players in the region include dsm, millipore sigma, and agilent technologies. in addition, research activities and innovative developments are taking place in the north american biocatalyst market. government initiatives such as the national institutes of health’s recombinant dna technology program and the protein engineering network of centers (prenct) have promoted research activities and investments in the field of biocatalysis in the region. also, various initiatives such as green chemistry commitment, igem (international genetically engineered machine) and the global research alliance’s sustainable industrial bio-materials program, are expected to drive regional market growth over the next decade. in conclusion, driven by the increasing demand for cost-effective biocatalysts, the north american biocatalyst market is poised to experience a surge in growth from 2018 to 2032. factors including government investments, research and innovation, and the presence of major global market players in the region are expected to support the growth of the regional biocatalyst market over the next 14 years.